NASHVILLE, Tenn., Oct. 28, 2016 /CNW/ -- Cumberland
Pharmaceuticals (NASDAQ: CPIX), based in Nashville, focused on specialty pharmaceuticals,
today announced that A.J. Kazimi, Chief Executive Officer of Cumberland Pharmaceuticals, will
present live at VirtualInvestorConferences.com on November 3, 2016.
DATE: Thursday, November 3, 2016
TIME: 11:30 AM ET
LINK: http://tinyurl.com/1103prepr
This will be a live, interactive online event where investors are invited to ask the company questions in real-time - both in
the presentation hall as well as the association's "virtual trade booth." If attendees are not able to join the event live on the
day of the conference, an on-demand archive will be available for 90 days.
It is recommended that investors pre-register and run the online system check to save time and receive event updates.
Learn more about the event at www.VirtualInvestorConferences.com.
Recent Company Highlights
- In May 2016, acquired exclusive US rights to Ethyol®.
- In September 2016, announced a fourth development candidate in pipeline with
Portaban™.
- Total net revenues during the first half of 2016 were $15 million resulting in adjusted
earnings of $2 million or $.13 per share
- Over $90 million in total assets, including over $50 million in
cash and marketable securities.
About Cumberland Pharmaceuticals
Cumberland Pharmaceuticals is a specialty pharmaceutical company that acquires, develops and commercializes branded
prescription products designed to improve quality of care and address unmet medical needs.
With a focus on underserved niche markets, including hospital acute care and gastroenterology, we deliver products that serve
patients in the U.S. market. Cumberland also makes its products available to patients
internationally through select strategic partnerships.
While Cumberland's commercial capabilities are focused on the U.S. market, our business
development team is actively pursuing opportunities to make our brands available to patients in markets around the globe.
Our primary mission is to improve upon patient care with products that offer clear advantages over existing treatments. We also
strive to deliver solutions that may help reduce costs for healthcare providers and, ultimately, patients. For more information,
visit our website at http://www.cumberlandpharma.com/
About VirtualInvestorConferences.com
Since 2010, VirtualInvestorConferences.com, created by BetterInvesting (NAIC) and PRNewswire, has
been the only monthly virtual investor conference series that provides an interactive forum for presenting companies to meet
directly with investors using a graphically-enhanced online platform.
Designed to replicate the look and feel of location-based investor conferences, Virtual Investor Conferences unites PR
Newswire's leading-edge online conferencing and investor communications capabilities with BetterInvesting's extensive retail
investor audience network.
Logo - http://photos.prnewswire.com/prnh/20160129/327291LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/cumberland-pharmaceuticals-to-webcast-live-at-virtualinvestorconferencescom-november-3-300353322.html
SOURCE Cumberland Pharmaceuticals
